Regulatory Approach to Point-of-Care/At-Home Testing in the United States
Description
                The Clinical Laboratory Improvement Amendments (CLIA) classifications were activated in the 1990s in partnership with the Centers for Medicare and Medicaid Services and Food and Drug Administration and included waived, moderate, and high complexity
          